Latest News & Features
Refine Search
Americas
Eli Lilly has filed a complaint against France-based biotechnology company Adocia over patents relating to fast-acting insulin. 11 October 2018
Biotechnology
Cancer biosimilars are slow to enter European drugs markets even after the branded products have gone off-patent, according to the Association of European Cancer Leagues. 11 October 2018
Americas
The US Food and Drug Administration has released guidance intended to advance the development of generic versions of complex medical drugs. 11 October 2018
Americas
Biologics patent owners should consider the US International Trade Commission as a supplement (or alternative) to district court litigation, say Filko Prugo, Charlotte Jacobsen, Matt Rizzolo and Henry Huang of Ropes & Gray. 10 October 2018
Americas
The US Court of Appeals for the Federal Circuit yesterday upheld a district court ruling that invalidated a patent owned by Roche Molecular Systems, a division of Roche that makes equipment and reagents. 10 October 2018
Americas
Tom Duley has joined Sidley Austin after spending nearly five years at King & Spalding. 10 October 2018
Americas
A proposed amendment in Mexican law needs to be implemented urgently in order to adapt legislation to include provisions in accordance with the UPOV Convention, as Luz Flores of Uhthoff, Gómez Vega & Uhthoff reports. 10 October 2018
Americas
A former Johnson & Johnson IP counsel and a retired judge are among the speakers at Life Sciences IP Due Diligence, on November 29 and 30 in Boston, as LSIPR finds out. 10 October 2018
Americas
North Carolina-based Duke University and Allergan have brought their patent dispute with medical company Alcon Laboratories to an end in Delaware. 9 October 2018
Americas
The IP concessions in the United States-Mexico-Canada Agreement are the latest hit for access to affordable prescription medicines for Canadians, according to the Canadian Generic Pharmaceutical Association. 9 October 2018